8 Recruiting Mild Cognitive Impairment Phase 1 Clinical Trials
Active phase 1 studies for mild cognitive impairment enrolling across the USA. Verify eligibility and contact site coordinators.
All Mild Cognitive Impairment studiesPhase 1 Studies for Mild Cognitive Impairment
🔵 Active, Not Recruiting Early Phase1
Glutathione in Mild Cognitive Impairment
📍 Baylor College of Medicine — Houston, Texas
View Study & Checklist ➔ 🔵 Active, Not Recruiting Early Phase1
Safety and Feasibility of Exablate Blood-Brain Barrier Disruption for Mild Cognitive Impairment or Mild Alzheimer's Disease Undergoing Standard of Care Monoclonal Antibody (mAb) Therapy
📍 West Virginia University Rockefeller Neuroscience Institute — Morgantown, West Virginia
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase1 / Phase2
ALSENLITE: Senolytics for Alzheimer's Disease
📍 Mayo Clinic in Rochester — Rochester, Minnesota
View Study & Checklist ➔ 🟢 Recruiting Phase1 / Phase2
Sense4Safety Intervention
📍 University of Pennsylvania — Philadelphia, Pennsylvania
View Study & Checklist ➔ 🟢 Recruiting Phase1
Safety and Target Engagement of Centella Asiatica in Cognitive Impairment
📍 Oregon Health & Science University — Portland, Oregon
View Study & Checklist ➔ 🟢 Recruiting Phase1
CogT pSOPT Intervention Study
📍 CogT Lab, Stanford University — Palo Alto, California
View Study & Checklist ➔ 🟢 Recruiting Phase1
TREAD: Time Restricted Eating Intervention for Alzheimer's Disease
📍 Shiley Marcos Alzheimer's Disease Center — San Diego, California
View Study & Checklist ➔ 🟢 Recruiting Phase1
Innate Immunity Stimulation Via TLR9 in Early AD
📍 NYU Langone Health — New York, New York
View Study & Checklist ➔